ERBB2 and breast cancer: To examine whether MED1 participates in HER2-mediated breast tumorigenesis in vivo, Yang et al. [57] crossed the MED1 LxxLL-mutant knock-in mice with mammary tumor-prone MMTV-HER2 mice whose tumorigenesis was driven by the oncogene HER2.